| Product Information |
|
| Registration Number |
DR-XY48976
|
| Generic Name |
Dolutegravir (as sodium) + Lamivudine + Tenofovir
Disoproxil (as fumarate)
|
| Brand Name |
None
|
| Dosage Strength |
50 mg/300 mg/300 mg
|
| Dosage Form |
Film-Coated Tablet
|
| Classification |
Prescription (Rx) Drug
|
| Pharmacologic Category |
Direct Acting Antiviral
|
| Packaging |
White Opaque HDPE Bottle with White Opaque.
Polyproylene Child Resistant Closure (Box of 30's and
90's)
|
| Manufacturer |
Aurobindo Pharma Limited -Unit X
|
| Country of Origin |
India
|
| Trader |
|
| Importer |
S.M.H.P. Marketing & Consultancy
|
| Distributor |
S.M.H.P. Marketing & Consultancy
|
| Application Type |
Monitored release
|
| Issuance Date |
10 January 2024
|
| Expiry Date |
10 January 2029
|